上(shang)(shang)證報中(zhong)國(guo)證券(quan)網(wang)訊（記者 盛波）8日(ri)，新三(san)板公(gong)司津同仁(ren)堂發(fa)布公(gong)告稱，公(gong)司2018年(nian)(nian)(nian)4月(yue)(yue)10日(ri)向證監會(hui)報送(song)了首(shou)(shou)次(ci)(ci)(ci)公(gong)開(kai)(kai)發(fa)行股(gu)(gu)(gu)票(piao)并(bing)在主板上(shang)(shang)市(shi)(shi)的申(shen)請(qing)(qing)文件(jian)；2018年(nian)(nian)(nian)4月(yue)(yue)17日(ri)領取(qu)了證監會(hui)出具的第180425號《中(zhong)國(guo)證監會(hui)行政許可申(shen)請(qing)(qing)受理通(tong)知書》；2018年(nian)(nian)(nian)4月(yue)(yue)20日(ri)，公(gong)司招股(gu)(gu)(gu)說明書（申(shen)報稿）在證監會(hui)網(wang)站（//www.csrc.gov.cn）預(yu)先(xian)披(pi)露。現(xian)由(you)于公(gong)司調整上(shang)(shang)市(shi)(shi)計劃，經過(guo)認(ren)真研究(jiu)和審慎考慮，擬終止本(ben)次(ci)(ci)(ci)首(shou)(shou)次(ci)(ci)(ci)公(gong)開(kai)(kai)發(fa)行股(gu)(gu)(gu)票(piao)并(bing)上(shang)(shang)市(shi)(shi)申(shen)請(qing)(qing)，并(bing)撤(che)回(hui)(hui)相關申(shen)請(qing)(qing)文件(jian)。公(gong)司于2020年(nian)(nian)(nian)12月(yue)(yue)8日(ri)召開(kai)(kai)2020年(nian)(nian)(nian)第五次(ci)(ci)(ci)臨時股(gu)(gu)(gu)東大會(hui)，審議通(tong)過(guo)《關于撤(che)回(hui)(hui)公(gong)司首(shou)(shou)次(ci)(ci)(ci)公(gong)開(kai)(kai)發(fa)行股(gu)(gu)(gu)票(piao)并(bing)上(shang)(shang)市(shi)(shi)申(shen)請(qing)(qing)的議案》，并(bing)向證監會(hui)申(shen)請(qing)(qing)撤(che)回(hui)(hui)首(shou)(shou)次(ci)(ci)(ci)公(gong)開(kai)(kai)發(fa)行股(gu)(gu)(gu)票(piao)并(bing)在主板上(shang)(shang)市(shi)(shi)的申(shen)請(qing)(qing)文件(jian)。

　　資料顯示，公(gong)司是(shi)一(yi)家(jia)集中成藥(yao)研發、生(sheng)產(chan)和銷售為一(yi)體的集團公(gong)司，擁(yong)有兩(liang)家(jia)醫(yi)(yi)藥(yao)生(sheng)產(chan)企業、兩(liang)家(jia)醫(yi)(yi)藥(yao)銷售企業。